SRZN - Surrozen, Inc./DE
28.14
-2.495 -8.866%
Share volume: 111,009
Last Updated: 04-24-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.22%
PREVIOUS CLOSE
CHG
CHG%
$30.64
-2.50
-0.08%
Summary score
35%
Profitability
35%
Dept financing
43%
Liquidity
50%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-39.02%
Return on sales
-1115.09%
Return on invested capital
0%
Total debt ratio
117.15%
Debt ratio change over timeo
0%
Current Ratio
8.66%
Quick Ratio
0%
Cash Position Ratio
7.81%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-49.33%
Return on sales
-1490.9%
Return on invested capital
0%
Total debt ratio
170.08%
Debt ratio change over timeo
0%
Current Ratio
10.8%
Quick Ratio
0%
Cash Position Ratio
10.35%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-31.89%
Return on sales
-2393.75%
Return on invested capital
0%
Total debt ratio
290.18%
Debt ratio change over time
0%
Current Ratio
9.22%
Quick Ratio
0%
Cash Position Ratio
8.99%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SRZN | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 5.97% | 8.91% |
| Return on assets | -39.02% | 2.97% | 3.34% | 2.04% |
| Return on sales | -1115.09% | 27.71% | 27.82% | 21.49% |
| Return on invested capital | 0% | 0% | 3.51% | 10.25% |
| Profitability | 0% | 47% | 75% | 85% |
| Total debt ratio | 117.15% | 93.27% | 65.75% | 43.64% |
| Debt ratio change over time | 0% | 14.34% | 187.33% | 9.75% |
| Dept financing | 25% | 22% | 39% | 11% |
| Current Ratio | 10.8% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 10.35% | 0.39% | 0.58% | 0.86% |
| Liquididy | 50% | 27% | 23% | 34% |
| Short-term ratios | SRZN | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -49.33% | 3.27% | 4.7% | 1.36% |
| Return on sales | -1490.9% | 24.35% | 34.09% | 15.11% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 35% | 50% | 18% |
| Total debt ratio | 170.08% | 91.09% | 63.87% | 38.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 13% | 9% | 6% |
| Current Ratio | 10.8% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 10.35% | 0.39% | 0.58% | 0.86% |
| Liquididy | 50% | 17% | 23% | 32% |